Advertisement
Home »

CMV Consensus Group Clarifies Parameters for PCR & Refractory Disease

Sep 30, 2024

REFERENCES & ADDITIONAL READING

Cuellar-Rodriguez JM, van Duin D. Cytomegalovirus disease: fine-tuning clinical trial enrollment and standardization. Clin Infect Dis. Published online July 29, 2024. doi:10.1093/cid/ciae319

Ljungman P, et al. Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the Transplant Associated Virus Infections Forum. Clin Infect Dis. Published online July 23, 2024. doi:10.1093/cid/ciae321.

ABOUT THE EXPERTS

  • David van Duin, MD, PhD
    Professor of Medicine
    Director of Immunocompromised Host Infectious Diseases Section
    UNC School of Medicine

     

    Jennifer M. Cuellar-Rodriguez, MD
    Staff Clinician
    Director of Transplant Infectious Diseases Consult Service
    National Institute of Allergy and Infectious Disease

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement